Clinical trial
Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease (Evol-PAD)
NCT04306081 is registered in ClinicalTrials.gov with Leonardo Clavijo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease (Evol-PAD)
- Lead sponsor
- Leonardo Clavijo
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 14, 2017
- Completion date
- March 30, 2021
- Enrollment
- 86 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.